BioCentury | May 26, 2014
Company News
Akers Biosciences, Jai Capital deal
...to the hospital and surgery markets in India. Akers declined to disclose financial terms, and Jai Capital...
...Transfusion Card is marketed to the U.S. military. Akers Biosciences Inc. (NASDAQ:AKER; LSE:AKR), Thorofare, N.J. Jai Capital LLC...
...Transfusion Card is marketed to the U.S. military. Akers Biosciences Inc. (NASDAQ:AKER; LSE:AKR), Thorofare, N.J. Jai Capital LLC...